Research has indicated that T-MPs influence the immunogenic phenotype of DCs and produce potent anti-tumor immunity in processes of prevention and therapy by mediating antigen transfer from macrophages to DCs and inducing type I interferon production via the cGAS/STING pathway. Here, STING1 is linked to neoplasm.